---
title: "Suzhou Basecare Calls 2025 AGM to Approve Reports, Budget and Capital Mandates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286128253.md"
description: "Suzhou Basecare Medical Corp. Ltd. has scheduled its 2025 annual general meeting for June 4, 2026, in Suzhou. Shareholders will review key reports, vote on the 2026 budget, profit distribution, director remuneration, and the re-appointment of KPMG as auditor. They will also consider granting the board mandates for share issuance and repurchase, along with proposed amendments to the Articles of Association. The meeting will include details on proxy voting and the share register closure for H-shareholders."
datetime: "2026-05-12T14:47:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286128253.md)
  - [en](https://longbridge.com/en/news/286128253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286128253.md)
---

# Suzhou Basecare Calls 2025 AGM to Approve Reports, Budget and Capital Mandates

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has issued an update.

Suzhou Basecare Medical Corporation Limited has called its 2025 annual general meeting for June 4, 2026, in Suzhou, where shareholders will review key 2025 corporate reports, including board and supervisory reports, the annual report, and the group’s financial statements. They will also vote on the 2026 financial budget, the 2025 profit distribution plan, director remuneration, and the re-appointment of KPMG as auditor.

Shareholders will further consider granting the board general mandates to issue additional shares and repurchase H shares, as well as proposed amendments to the Articles of Association, moves that could provide the company with greater financial and capital management flexibility. The notice also outlines procedural details for proxy voting, poll-based resolution approval, and the share register closure period for H-shareholders entitled to participate in the meeting.

**More about Suzhou Basecare Medical Corp. Ltd. Class H**

Suzhou Basecare Medical Corporation Limited is a medical technology company based in Suzhou, Jiangsu Province, China, and listed in Hong Kong. The company operates in the healthcare and diagnostics sector, focusing on genetic testing and related medical solutions for the Chinese and broader Asian markets.

**Average Trading Volume:** 109,363

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$527.9M

### Related Stocks

- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [512170.CN](https://longbridge.com/en/quote/512170.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [02170.HK](https://longbridge.com/en/quote/02170.HK.md)

## Related News & Research

- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [Basecare Wins NMPA Class III Approval for Gems Embryo Culture Medium](https://longbridge.com/en/news/286258287.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)